Overtaking Intra and Inter Tumoral Heterogeneity In Von Hippel-Lindau Related Renal Cancer
NCT06195150 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 3
Last updated 2026-05-11
Summary
The goal of this study is to comprehensively map intra and inter tumor heterogeneity of ccRCC in VHL patients through the use of imaging, molecular biology and genomics techniques.
Conditions
- Clear Cell Renal Cell Carcinoma
- VHL Syndrome
Interventions
- OTHER
-
Blood collection
15ml of blood are harvested before surgery
Sponsors & Collaborators
-
IRCCS San Raffaele
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 99 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-11-08
- Primary Completion
- 2026-05-19
- Completion
- 2026-05-19
Countries
- Italy
Study Locations
More Related Trials
-
Kidney Cancer Observational Protocol
NCT06147349 ·Status: RECRUITING
-
Percutaneous Tumor Ablation Vs Partial Nephrectomy for Small Renal Mass: the Impact of Histologic Variant and Tumor Size
NCT06829888 ·Status: COMPLETED
-
Predicting Model Based on Evidence-based Pathological Diagnose Criteria for RCC Tumor Thrombus With IVC Wall Invasion
NCT05589207 ·Status: RECRUITING
-
Imaging-Guided Classification for Endophytic Renal Tumors: PN Strategies & Outcomes
NCT06954571 ·Status: ACTIVE_NOT_RECRUITING
-
Analysis of Predictive Factors for Urinary Leakage After Partial Nephrectomy for Renal Hilum Tumors
NCT06916910 ·Status: ACTIVE_NOT_RECRUITING
-
A Prospective Study to Evaluate the Implementation of Shared Decision Making Strategy for Renal Cell Cancer (RCC)
NCT05548621 ·Status: RECRUITING
-
Primary Tumor Ablation and Outcome in Metastatic Renal Cell Carcinoma Treated With Immunotherapy Combinations.
NCT06903312 ·Status: RECRUITING ·Phase: PHASE4
-
Perioperative Systemic Therapy for Isolated Resectable Colorectal Peritoneal Metastases
NCT02758951 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3
-
Visceral Fat Area as a Prognostic Biomarker in Clear Cell Renal Cell Carcinoma: A Multicenter Study on Postoperative Survival
NCT06791863 ·Status: COMPLETED
-
The Natural History of Small Renal Masses
NCT01305330 ·Status: COMPLETED
-
Prognostic Factor for Renal Cell Carcinoma (RCC) With Venous Tumor Thrombus
NCT01328691 ·Status: COMPLETED
-
Translational Cancer Observational Protocol
NCT06169436 ·Status: RECRUITING
-
Nephroureterectomy With and Without Lymph Node Dissection for Upper Tract Urothelial Cell Carcinoma
NCT06262516 ·Status: RECRUITING ·Phase: NA
-
Prospective Patient Reported Outcomes (PRO) Registry in Patients With Advanced Renal Cell Carcinoma
NCT02537743 ·Status: COMPLETED
-
Tumor Rupture During Robotic Partial Nephrectomy
NCT07065825 ·Status: NOT_YET_RECRUITING
-
Exhaustive Genetic and Immunological Characterization of Colon, Kidney and Liver Tumors
NCT03149523 ·Status: UNKNOWN
-
Study to Evaluate the Use of Resources and the Costs Associated With Carcinoid Syndrome (CS) in Patients With NETs in Spain
NCT03220087 ·Status: COMPLETED
-
Cytoreductive Surgery(CRS) Plus Hyperthermic Intraoperative Peritoneal Chemotherapy(HIPC) With Cisplatin to Treat Peritoneal Carcinomatosis From Upper Gastrointestinal Cancer
NCT01116791 ·Status: TERMINATED ·Phase: PHASE2
-
Perfusion Scanning's for Kidney Tumors
NCT01971905 ·Status: COMPLETED
-
A Feasibility Study for a Multicentre Randomised Controlled Trial to Compare Surgery With Needle Ablation Techniques in People With Small Renal Masses (4cm)
NCT01608165 ·Status: COMPLETED ·Phase: NA
-
Generation of Organoids of Neuroendocrine Neoplasms of the Gastro-Entero-Pancreatic Tract Obtained From Patients Undergoing Surgery
NCT06519500 ·Status: RECRUITING
-
Longitudinal Study of CRS/HIPEC for Peritoneal Carcinomatoses
NCT04108936 ·Status: RECRUITING
-
Analysis of Oncogenes in Intrahepatic Cholangiocarcinoma or Mixed Hepatocellular-Cholangiocarcinoma in Tumor Tissue Samples
NCT02762721 ·Status: COMPLETED
-
Evaluation of the Safety of Reoperation for Ipsilateral Recurrent Tumors After Nephron-sparing Partial Nephrectomy
NCT06317207 ·Status: COMPLETED
-
Image Driven Hepatocellular Carcinoma Invasiveness Evaluation Research
NCT06559761 ·Status: RECRUITING